Home › Research › Prevention and risk
Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs)
Yujing Zhou, Jing Liao, Yu‐Tzu Wu. Alzheimer s & Dementia, 2025-08-01
Topic: Risk, prevention and care in population studies
Plain-language summary
The 12 risk factors account for 60.3% of dementia cases in China, including 14.0% in early life, 8.8% in midlife, and 37.5% in later life. Some factors (e.g., alcohol abuse, depression) showed wide confidence intervals indicating lack of evidence. This study highlights the potential for dementia prevention in China, but more evidence is needed to estimate PAFs for specific risk factors (e.g., midlife factors). HIGHLIGHTS: We used the most recent and nationally representative data to calculate population attributable fractions (PAFs) for dementia risk factors in China. In China, 60.3% of dementia cases were attributed to the 12 modifiable risk factors. Education was estimated to contribute 14.0% of dementia cases, and 37.5% was attributed to later-life lifestyle and health factors in China. It is necessary to consider incorporating China-specific factors and updating the PAF calculation method.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This analysis estimates that 12 modifiable risk factors account for 60.3% of dementia cases in China, with 14.0% in early life, 8.8% in midlife, and 37.5% in later life. Reported effect size: or 60.3; 14.0%; 8.8%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Zhou, Y., Liao, J., & Wu, Y. (2025). Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs). Alzheimer s & Dementia. https://doi.org/10.1002/alz.70542
Vancouver
Zhou Y, Liao J, Wu Y. Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs). Alzheimer s & Dementia. 2025. doi:10.1002/alz.70542. PMID: 40879658.
BibTeX
@article{zhou2025-40879658,
author = {Zhou, Yujing and Liao, Jing and Wu, Yu‐Tzu},
title = {{Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs)}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.70542},
pmid = {40879658},
url = {https://doi.org/10.1002/alz.70542}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The 12 risk factors account for 60.3% of dementia cases in China, including 14.0% in early life, 8.8% in midlife, and 37.5% in later life.
- Some factors (e.g., alcohol abuse, depression) showed wide confidence intervals indicating lack of evidence.
- This study highlights the potential for dementia prevention in China, but more evidence is needed to estimate PAFs for specific risk factors (e.g., midlife factors).
- HIGHLIGHTS: We used the most recent and nationally representative data to calculate population attributable fractions (PAFs) for dementia risk factors in China.
- In China, 60.3% of dementia cases were attributed to the 12 modifiable risk factors.
Why it matters
This analysis estimates that 12 modifiable risk factors account for 60.3% of dementia cases in China, with 14.0% in early life, 8.8% in midlife, and 37.5% in later life. The authors note that some factors had wide confidence intervals indicating lack of evidence, and that more evidence is needed for specific risk factors.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designlongitudinal study
- Effect sizeor 60.3; 14.0%; 8.8%
- Evidence strengthModerate
How this study scored 48/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Yu‐Tzu Wu: h-index 41 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Newcastle University: institution h-index 932 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40879658) |
| Free to read | 2 / 2 | Free to read |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.
Related studies in Prevention and risk from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.